The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

M. O. Holmstrom; E. Martinenaite; S. M. Ahmad; O. Met; C. Friese; L. Kjaer; C. H. Riley; P. thor Straten; I. M. Svane; H. C. Hasselbalch; M. H. Andersen

doi:10.1038/leu.2017.214

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

M. O. Holmstrom, E. Martinenaite, S. M. Ahmad, O. Met, C. Friese, L. Kjaer, C. H. Riley, P. thor Straten, I. M. Svane, H. C. Hasselbalch, M. H. Andersen

Institut for Klinisk Medicin

47 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Leukemia
Vol/bind	32
Udgave nummer	2
Sider (fra-til)	429-437
ISSN	0887-6924
DOI	https://doi.org/10.1038/leu.2017.214
Status	Udgivet - 1 feb. 2018

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1038/leu.2017.214

Citationsformater

@article{abde5b9cfb3f48df947df206d0514772,

title = "The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy",

author = "Holmstrom, {M. O.} and E. Martinenaite and Ahmad, {S. M.} and O. Met and C. Friese and L. Kjaer and Riley, {C. H.} and Straten, {P. thor} and Svane, {I. M.} and Hasselbalch, {H. C.} and Andersen, {M. H.}",

year = "2018",

month = feb,

day = "1",

doi = "10.1038/leu.2017.214",

language = "English",

volume = "32",

pages = "429--437",

journal = "Leukemia",

issn = "0887-6924",

publisher = "nature publishing group",

number = "2",

}

TY - JOUR

T1 - The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

AU - Holmstrom, M. O.

AU - Martinenaite, E.

AU - Ahmad, S. M.

AU - Met, O.

AU - Friese, C.

AU - Kjaer, L.

AU - Riley, C. H.

AU - Straten, P. thor

AU - Svane, I. M.

AU - Hasselbalch, H. C.

AU - Andersen, M. H.

PY - 2018/2/1

Y1 - 2018/2/1

U2 - 10.1038/leu.2017.214

DO - 10.1038/leu.2017.214

M3 - Journal article

C2 - 28676668

SN - 0887-6924

VL - 32

SP - 429

EP - 437

JO - Leukemia

JF - Leukemia

IS - 2

ER -

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater